Previous studies have shown that RAAS blockade lowers disastolic pressure in hypertensive patients [40] and improves hemodynamics in mouse models of Marfan syndrome via inhibition of TGFβ signaling and prevention of elastic fiber fragmentation [41]. The gene discussed is TGFB1; the disease is Marfan syndrome.